Michael Thomas Heffernan - Dec 22, 2022 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
Director
Signature
/s/ Colleen Tupper as Attorney-In-Fact For Michael T. Heffernan
Stock symbol
COLL
Transactions as of
Dec 22, 2022
Transactions value $
-$186,039
Form type
4
Date filed
12/27/2022, 06:17 PM
Previous filing
Dec 21, 2022
Next filing
May 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Options Exercise $3.83K +237 +0.85% $16.15 28.3K Dec 22, 2022 Direct
transaction COLL Common Stock Sale -$5.45K -237 -0.84% $23.00 28K Dec 22, 2022 Direct F1
transaction COLL Common Stock Options Exercise $80.6K +4.99K +17.8% $16.15 33K Dec 23, 2022 Direct
transaction COLL Common Stock Sale -$115K -4.99K -15.11% $23.00 28K Dec 23, 2022 Direct F1, F2
transaction COLL Common Stock Options Exercise $258K +16K +57.08% $16.15 44K Dec 27, 2022 Direct
transaction COLL Common Stock Sale -$378K -16K -36.34% $23.63 28K Dec 27, 2022 Direct F1, F3
transaction COLL Common Stock Options Exercise $61.7K +3.82K +13.63% $16.15 31.8K Dec 27, 2022 Direct
transaction COLL Common Stock Sale -$92.3K -3.82K -12% $24.16 28K Dec 27, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -237 -0.95% $0.00 24.8K Dec 22, 2022 Common Stock 237 $16.15 Direct F5
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -4.99K -20.11% $0.00 19.8K Dec 23, 2022 Common Stock 4.99K $16.15 Direct F5
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -16K -80.72% $0.00 3.82K Dec 27, 2022 Common Stock 16K $16.15 Direct F5
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -3.82K -100% $0.00* 0 Dec 27, 2022 Common Stock 3.82K $16.15 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
F3 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F4 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).
F5 The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.